← Back to Clinical Trials
Recruiting NCT05794061

NCT05794061 Advances in Neuropsychological Diagnostics

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05794061
Status Recruiting
Phase
Sponsor Istituto Auxologico Italiano
Condition Cognitive Impairment
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2021-11-11
Primary Completion 2026-12-31

Trial Parameters

Condition Cognitive Impairment
Sponsor Istituto Auxologico Italiano
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 20 Years
Max Age 100 Years
Start Date 2021-11-11
Completion 2026-12-31
Interventions
Neuropsychological instruments

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This project is aimed at advancing neuropsychological diagnostics, enriching and modernizing the panorama of both clinical and forensic psychometric testing. The rapid socio-demographic changes, the developments of neuropsychological semiotics and nosography, as well as the growing applicative specialization of neuropsychological assessment make it necessary to introduce further tools to satisfy the diagnostic requests in clinical contexts and more recently in the forensic field (i.e., tests to be administered remotely; bedside screeners; domain-specific in-depth tests; tools for assessing testamentary capacity). Specifically, the present study aims to: a) develop, calibrate and evaluate the psychometric properties of I and II level clinical and/or forensic neuropsychological tests evaluating instrumental and non-instrumental functions in a sample of neurologically healthy individuals representative of the Italian population ; b) evaluate the cross-sectional and longitudinal clinical usability of the aforementioned tests in clinical samples (patients with neurological and neuropsychiatric pathologies of different etiology).

Eligibility Criteria

Inclusion Criteria: * Clinical populations: clinical diagnosis of either neurological (e.g., vascular and degenerative aetiologies) or psychiatric disorders. * Healthy controls: not applicable Exclusion Criteria: * Clinical populations: 1. Clinical diagnosis not of interest; 2. Severe general medical conditions; 3. Uncorrected vision/hearing deficits. * Healthy controls: 1. Presence of brain disorders; 2. Severe general medical conditions; 3. Uncorrected vision/hearing deficits.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology